REPH
$8.05
Recro Pharma
$.45
5.92%
REPH
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  $0.01
Revenue:  N/A
Wednesday
Mar 4
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when REPH reports earnings?
Beat
Meet
Miss

Where is REPH's stock price going from here?
Up
Flat
Down
Stock chart of REPH
Analysts
Summary of analysts' recommendations for REPH
Score
Grade
Pivots
Resistance
$9.19
$8.70
$8.38

$7.89

Support
$7.57
$7.08
$6.76
Tweet
Growth
Peers
Regeneron PharmaceuticalsBioMarin PharmaceuticalVertex PharmaceuticalsJohnson & JohnsonInterCeptZoetisBristol-Myers SquibbMylanUltragenyx PharmaceuticalAlkermes